Your browser doesn't support javascript.
loading
Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer.
Takakura, Kazuki; Koido, Shigeo; Kan, Shin; Yoshida, Kosaku; Mori, Masako; Hirano, Yuta; Ito, Zensho; Kobayashi, Hiroko; Takami, Shinichiro; Matsumoto, Yoshihiro; Kajihara, Mikio; Misawa, Takeyuki; Okamoto, Masato; Sugiyama, Haruo; Homma, Sadamu; Ohkusa, Toshifumi; Tajiri, Hisao.
Afiliação
  • Takakura K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Koido S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan Institute of Clinical Medicine and Research, The Jikei University School of Medicine, Tokyo, Japan Department of Oncology, The Jikei University School of Medicine, Toky
  • Kan S; Department of Oncology, The Jikei University School of Medicine, Tokyo, Japan.
  • Yoshida K; Research and Development Division, Tella Inc., Tokyo, Japan.
  • Mori M; Research and Development Division, Tella Inc., Tokyo, Japan.
  • Hirano Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Ito Z; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Kobayashi H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Takami S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Matsumoto Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Kajihara M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Misawa T; Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Okamoto M; Department of Advanced Immunotherapeutics, Kitasato University School of Pharmacy, Tokyo, Japan.
  • Sugiyama H; Department of Functional Diagnostic Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Homma S; Department of Oncology, The Jikei University School of Medicine, Tokyo, Japan.
  • Ohkusa T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Tajiri H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Anticancer Res ; 35(1): 555-62, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25550602
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antígenos de Histocompatibilidade Classe I / Adenocarcinoma / Antígenos de Histocompatibilidade Classe II / Vacinas Anticâncer / Proteínas WT1 Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antígenos de Histocompatibilidade Classe I / Adenocarcinoma / Antígenos de Histocompatibilidade Classe II / Vacinas Anticâncer / Proteínas WT1 Idioma: En Ano de publicação: 2015 Tipo de documento: Article